Table 4.
Clinical features of clear cell tumors compared to Type I tumors, Type II tumors and Type I and II tumors in one group
| |
N (%) |
N (%) |
N (%) |
N (%) |
N (%) |
N (%) |
|---|---|---|---|---|---|---|
| |
16 (29) |
40 (61) |
16 (18) |
75 (82) |
16 (12) |
115 (88) |
| |
Clear cell |
Type I |
Clear cell |
Type II |
Clear cell |
Other (Type I+II) |
| Tumors | Tumors | Tumors | Tumors | Tumors | Tumors | |
| Age |
54.7 |
57.2 |
54.7 |
60.2 |
54.7 |
59.1 |
| |
p = 0.388 |
|
p = 0.046 |
|
p = 0.100 |
(t-test) |
| BMI ≤ 25 |
11 (73) |
11 (36) |
11 (73) |
44 (61) |
11 (73) |
58 (52) |
| BMI > 25 |
4 (27) |
25 (64) |
4 (27) |
28 (39) |
4 (27) |
53 (48) |
| |
p = 0.013 |
|
p = 0.372 |
|
p = 0.123 |
(chi-2) |
| STAGE |
|
|
|
|
|
|
| IA-B |
3 (19) |
20 (50) |
3 (19) |
22 (29) |
3 (19) |
42 (19) |
| IC |
10 (62) |
16 (40) |
10 (62) |
40 (54) |
10 (62) |
56 (49) |
| II |
3 (19) |
4 (10) |
3 (19) |
13 (17) |
3 (19) |
17 (15) |
| |
p = 0.097 |
|
p = 0.669 |
|
p = 0.341 |
(chi-2) |
| Capsule |
|
|
|
|
|
|
| Rupture* |
|
|
|
|
|
|
| Yes |
10 (63) |
13 (33) |
10 (63) |
39(34) |
10 (63) |
26 (35) |
| No |
6 (37) |
27 (67) |
6 (37) |
76 (66) |
6 (37) |
49 (65) |
| |
p = 0.039 |
|
p = 0.027 |
|
p = 0.039 |
(chi-2) |
| Recurrence |
|
|
|
|
|
|
| Without |
12 (75) |
31 (77) |
12 (75) |
54 (69) |
12 (75) |
85 (74) |
| With |
4 (25) |
9 (23) |
4 (25) |
21 (31) |
4 (25) |
30 (26) |
| p = 0.841 | p = 0.807 | p = 0.926 | (chi-2) |
* Capsule of the tumor is perforated before or at primary surgery.